Point Estimation: Odds Ratios, Hazard Ratios, Risk Differences, Precision - PowerPoint PPT Presentation

About This Presentation
Title:

Point Estimation: Odds Ratios, Hazard Ratios, Risk Differences, Precision

Description:

Clinical Trials in 20 Hours Point Estimation: Odds Ratios, Hazard Ratios, Risk Differences, Precision Elizabeth S. Garrett esg_at_jhu.edu Oncology Biostatistics – PowerPoint PPT presentation

Number of Views:552
Avg rating:3.0/5.0
Slides: 33
Provided by: peopleMu3
Learn more at: http://people.musc.edu
Category:

less

Transcript and Presenter's Notes

Title: Point Estimation: Odds Ratios, Hazard Ratios, Risk Differences, Precision


1
Point EstimationOdds Ratios, Hazard Ratios,
Risk Differences, Precision
Clinical Trials in 20 Hours
  • Elizabeth S. Garrett
  • esg_at_jhu.edu
  • Oncology Biostatistics
  • March 20, 2002

2
Point Estimation
  • Definition A point estimate is a one-number
    summary of data.
  • If you had just one number to summarize the
    inference from your study..
  • Examples
  • Dose finding trials MTD (maximum tolerable
    dose)
  • Safety and Efficacy Trials response rate,
    median survival
  • Comparative Trials Odds ratio, hazard ratio

3
Types of Variables
  • The point estimate you choose depends on the
    nature of the outcome of interest
  • Continuous Variables
  • Examples change in tumor volume or tumor
    diameter
  • Commonly used point estimates mean, median
  • Binary Variables
  • Examples response, progression, gt 50 reduction
    in tumor size
  • Commonly used point estimate proportion,
    relative risk, odds ratio
  • Time-to-Event (Survival) Variables
  • Examples time to progression, time to death,
    time to relapse
  • Commonly used point estimates median survival,
    k-year survival, hazard ratio
  • Other types of variables nominal categorical,
    ordinal categorical

4
Today
  • Point Estimates commonly seen (and misunderstood)
    in clinical oncology
  • odds ratio
  • risk difference
  • hazard ratio/risk ratio

5
Point Estimates Odds Ratios
  • Age, Sex, and Racial Differences in the Use of
    Standard Adjuvant Therapy for Colorectal Cancer,
    Potosky, Harlan, Kaplan, Johnson, Lynch. JCO,
    vol. 20 (5), March 2002, p. 1192.
  • Example Is gender associated with use of
    standard adjuvant therapy (SAT) for patients with
    newly diagnosed stage III colon or stage II/III
    rectal cancer?
  • 53 of men received SAT
  • 62 of women received SAT
  • How do we quantify the difference?

adjusted for other variables
6
Odds and Odds Ratios
  • Odds p/(1-p)
  • The odds of a man receiving SAT is 0.53/(1 -
    0.53) 1.13.
  • The odds of a woman receiving SAT is 0.62/(1 -
    0.62) 1.63.
  • Odds Ratio 1.63/1.13 1.44
  • Interpretation A woman is 1.44 times more
    likely to receive SAT than a man.

7
Odds Ratio
  • Odds Ratio for comparing two proportions
  • OR gt 1 increased risk of group 1 compared to
    2
  • OR 1 no difference in risk of group 1
    compared to 2
  • OR lt 1 lower risk (protective) in risk of
    group 1 compared to 2
  • In our example,
  • p1 proportion of women receiving SAT
  • p2 proportion of men receiving SAT

8
Odds Ratio from a 2x2 table
9
(No Transcript)
10
More on the Odds Ratio
  • Ranges from 0 to infinity
  • Tends to be skewed (i.e. not symmetric)
  • protective odds ratios range from 0 to 1
  • increased risk odds ratios range from 1 to ?
  • Example
  • Women are at 1.44 times the risk/chance of men
  • Men are at 0.69 times the risk/chance of women

11
More on the Odds Ratio
  • Sometimes, we see the log odds ratio instead of
    the odds ratio.
  • The log OR comparing women to men is log(1.44)
    0.36
  • The log OR comparing men to women is log(0.69)
    -0.36
  • log OR gt 0 increased risk
  • log OR 0 no difference in risk
  • log OR lt 0 decreased risk

12
Related Measures of Risk
  • Relative Risk RR p1/p2
  • RR 0.62/0.53 1.17.
  • Different way of describing a similar idea of
    risk.
  • Generally, interpretation in words is the
    similar
  • Women are at 1.17 times as likely as men to
    receive SAT
  • RR is appropriate in trials often.
  • But, RR is not appropriate in many settings (e.g.
    case-control studies)
  • Need to be clear about RR versus OR
  • p1 0.50, p2 0.25.
  • RR 0.5/0.25 2
  • OR (0.5/0.5)/(0.25/0.75) 3
  • Same results, but OR and RR give quite different
    magnitude

13
Related Measures of Risk
  • Risk Difference p1 - p2
  • Instead of comparing risk via a ratio, we compare
    risks via a difference.
  • In many CTs, the goal is to increase response
    rate by a fixed percentage.
  • Example the current success/response rate to a
    particular treatment is 0.20. The goal for new
    therapy is a response rate of 0.40.
  • If this goal is reached, then the risk
    difference will be 0.20.

14
Why do we so often see OR and not others?
  • (1) Logistic regression
  • Allows us to look at association between two
    variables, adjusted for other variables.
  • Output is a log odds ratio.
  • Example In the gender SAT example, the odds
    ratios were evaluated using logistic regression.
    In reality, the gender SAT odds ratio is
    adjusted for age, race, year of dx, region,
    marital status,..
  • (2) Can be more globally applied. Design of
    study does not restrict usage.

15
Another Example
  • Randomized Controlled Trial of Single-Agent
    Paclitaxel Versus Cyclophosphamide, Doxorubicin,
    and Cisplatin in Patients with Recurrent Ovarian
    Cancer Who Responded to First-line Platinum-Based
    Regimens, Cantu, Parma, Rossi, Floriani,
    Bonazzi, DellAnna, Torri, Colombo. JCO, vol. 20
    (5), March 2002, p. 1232.
  • Groups paclitaxel (n 47) versus CAP (n 47)
  • 14 patients in the CAP group and 8 patients in
    the paclitaxel group had complete responses
  • p1 14/47 0.30 p2 8/47 0.17
  • OR (0.30/0.70)/(0.17/0.83) 2.1

16
Odds Ratio via 2x2 table
  • 14 patients in the CAP group and 8 patients in
    the paclitaxel group had complete responses
  • Patients in the CAP group are twice as likely to
    have a CR as those in the paclitaxel group.
  • 2x2 Table approach
  • OR ad/bc
  • (1439)/(833) 2.1

17
Point Estimates Hazard Ratios
Randomized Controlled Trial of Single-Agent
Paclitaxel Versus Cyclophosphamide, Doxorubicin,
and Cisplatin in Patients with Recurrent Ovarian
Cancer Who Responded to First-line
Platinum-Based Regimens, Cantu, Parma, Rossi,
Floriani, Bonazzi, DellAnna, Torri, Colombo.
JCO, vol. 20 (5), March 2002, p. 1232.
  • What is the effect of CAP on overall survival as
    compared to paclitaxel?
  • Median survival in CAP group was 34.7 months.
  • Median survival in paclitaxel group was 25.8
    months.
  • But, median survival doesnt tell the whole
    story..

18
Hazard Ratio
  • Compares risk of event in two populations or
    samples
  • Ratio of risk in group 1 to risk in group 2
  • First things first..
  • Kaplan-Meier Curves (product-limit estimate)
  • Makes a picture of survival

19
Hazard Ratios
  • Assumption Proportional hazards
  • The risk does not depend on time.
  • That is, risk is constant over time
  • But that is still vague..
  • Hypothetical Example Assume hazard ratio is 2.
  • Patients in standard therapy group are at twice
    the risk of death as those in new drug, at any
    given point in time.
  • Hazard function P(die at time t survived to
    time t)

20
Hazard Ratios
  • Hazard Ratio hazard function for Std
  • hazard function for New
  • Makes the assumption that this ratio is constant
    over time.

21
Hazard Ratios
  • Hazard Ratio hazard function for Pac
  • hazard function for CAP
  • Makes the assumption that this ratio is constant
    over time.

HR 2
?
22
Hazard Ratios
  • Hazard Ratio hazard function for Pac
  • hazard function for CAP
  • Makes the assumption that this ratio is constant
    over time.

HR 2
?
HR 2
?
23
Interpretation Again
  • For any fixed point in time, individuals in the
    standard therapy group are at twice the risk of
    death as the new drug group.

HR 2
?
HR 2
?
24
Hazard ratio is not always valid .

Hazard Ratio .71
25
CAP vs. Paclitaxel
  • Hazard Ratio for Progression Free Survival
    0.60 for CAP vs. Paclitaxel

26
CAP vs. Paclitaxel
  • Hazard Ratio for Overall Survival 0.58 for CAP
    vs. Paclitaxel

27
Introduction to Precision Issues
  • Precision Variability
  • Two kinds of variability we tend to deal with
  • variation in the population how much do
    individuals tend to differ from one another?
  • variance of statistics how certain are we of
    our estimate of the odds ratio?
  • There might be great variability in the
    population, but with a large sample size, we can
    have very good precision for a sample statistic.

28
Standard Deviation
  • Standard deviation measures how much variability
    there is in a variable across individuals in the
    population
  • CD20 Expression in Hodgkin and Reed-Sternberg
    Cells of Classical Hodgkins Disease
    Associations with Presenting Features and
    Clinical Outcome, Rassidakis, Mederios, Viviani,
    et al. JCO, March 1, 2002, v. 20(5), p. 1278.

29
Standard Deviation
  • Mean
  • Standard Deviation

30
Other measures of precision for continuous
variables
  • Range the smallest and largest values of x
  • IQR (interquartile range) 25 percentile and
    75 percentile of the data

75-tile
25-tile
31
Precision
Standardized Uptake Value in 2-18F
Fluro-2-Deoxy-D- Glucose in Predicting Outcome in
Head and Neck Carcinomas Treated by Radiotherapy
With or Without Chemotherapy, Allal, Dulgerov,
Allaoua, Haeggeli, Ghazi, Lehmann, Slosman, JCO,
March 1, 2002, v. 20(5), p. 1398.

Event treatment failure
32
Next time Confidence Intervals
  • Measuring precision of statistics
  • Central limit theorem
  • Confidence intervals for
  • means
  • proportions
  • odds ratios
  • etc..
Write a Comment
User Comments (0)
About PowerShow.com